A Phase 3, Multicenter, Open Label, Randomized Study Of Abarelix Versus Leuprolide Plus Daily Antiandrogen In Men With Prostate Cancer
収録刊行物
-
- The Journal of Urology
-
The Journal of Urology 167 1670-1674, 2002-04
Ovid Technologies (Wolters Kluwer Health)